Using over-representation of metabolic pathways, we were able to show that individual LFs, and the main related pathological aspects of AD (i.e., amyloid aggregation, neurodegeneration and tau pathology) are associated with distinct pathways. The gene discussed is MAPT; the disease is Alzheimer disease.